Therapeutic Role of Gymnema sylvestre and Momordica charantia in Diabetes Management: A Detailed Review of Their Mechanisms in Insulin Resistance, Glucose Metabolism Regulation, and Clinical Efficacy in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, β-cell dysfunction, and impaired glucose metabolism. While conventional treatments like metformin and insulin therapy are widely used, interest in herbal and alternative medicine has grown due to their potential efficacy, fewer side effects, and complementary mechanisms.Among the promising botanical agents, Gymnema sylvestre and Momordica charantia have demonstrated antidiabetic properties in preclinical and clinical studies. Objectives: This review aims to: Examine the pathophysiology of T2DM, focusing on insulin resistance, glucose dysregulation, and oxidative stress. Analyze the mechanisms of action of Gymnema sylvestre and Momordica charantia in improving insulin sensitivity, stimulating insulin secretion, and regulating glucose metabolism. Evaluate clinical studies assessing their effectiveness in diabetes management. Compare their pharmacological effects and explore their potential for synergistic use. Highlight future research directions for improving their clinical applications. Methods: A comprehensive literature review was conducted using databases like PubMed, Scopus, and Google Scholar to identify in vitro, in vivo, and human clinical studies on Gymnema sylvestre and Momordica charantia in diabetes management. Relevant articles were selected based on mechanistic insights, clinical evidence, and safety considerations. Results” Gymnema sylvestre contains gymnemic acids, saponins, and flavonoids, which enhance insulin secretion, regenerate pancreatic β-cells, inhibit intestinal glucose absorption, and improve glucose uptake in peripheral tissues. Momordica charantia contains charantin, polypeptide-p, and vicine, which mimic insulin action, regulate glucose metabolism, and exert antioxidant and anti-inflammatory effects. Clinical trials suggest significant reductions in fasting blood glucose (FBG), postprandial glucose (PPG), and HbA1c in patients consuming extracts of these plants. However, variability in phytochemical composition and dosing regimens limits standardization. Comparative analysis shows overlapping mechanisms of action, suggesting that combining these herbs may have additive or synergistic benefits in glycemic control. Research gaps include a lack of large-scale, long-term clinical trials, inconsistencies in extract standardization, and insufficient safety data for chronic use. Conclusions: Gymnema sylvestre and Momordica charantia exhibit promising antidiabetic properties through multiple mechanisms, including insulin secretion enhancement, glucose uptake facilitation, and oxidative stress reduction. While existing evidence supports their potential as adjuncts to conventional diabetes therapies, further randomized controlled trials (RCTs), phytochemical standardization, and formulation innovations are needed to ensure efficacy, safety, and clinical integration.